300-08-3 Arecoline HBr AKSci J10116
 
 
Loading Please Wait...
  J10116    
Arecoline HBr
, >98% (HPLC)
 



IDENTITY
CAS Number:300-08-3
MDL Number:MFCD00039041
MF:C8H14BrNO2
MW:236.11
EINECS:206-087-3
BRN:3914826
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:>98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:168-176°C
Long-Term Storage:Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

REVIEW

 Arecoline is a natural product, an alkaloid found in the areca nut, the fruit of the areca palm (Areca catechu). In many Asian cultures, the areca nut is chewed along with betel leaf to obtain a stimulating effect. Betel quid chewing is an ancient practice common in many countries of Asia and among migrated communities in Africa, Europe and North America. It enjoys complete social acceptance in many societies and is also popular among women. In its most basic form, betel quid consists of betel leaf (Piper betel), areca nut, the main psychoactive ingredient, and slaked lime (calcium hydroxide). Areca nut is said to be the fourth most commonly used psychoactive substance in the world, after caffeine, nicotine and alcohol. Arecoline has been shown to be the primary active ingredient in areca nut responsible for the central nervous system effects of the areca nut. Arecoline is a partial agonist of muscarinic acetylcholine M1, M2, M3 receptors and M4,which is believed to be the primary cause of its parasympathetic effects (such as pupillary constriction, bronchial constriction, etc.). Owing to its muscarinic and nicotinic agonist properties, arecoline has shown improvement in the learning ability of healthy volunteers. Since one of the hallmarks of Alzheimer's disease is a cognitive decline, arecoline was suggested as a treatment to slow down this process and arecoline administered intravenously did indeed show modest verbal and spatial memory improvement in Alzheimer's patients However, due to arecoline's possible carcinogenic properties, it is not the first drug of choice for this degenerative disease. Efforts have been undertaken to improve on arecoline drug properties through modification of the core structure, and in particular use of biosteres to replace the labile methyl ester. Arecoline has also been used medicinally as an antihelmintic (a drug against parasitic worms).

REFERENCES
[1]Arjungi KN. Areca nut: a review. Arzneimittelforschung. 1976;26(5):951-6.
[2] Gupta PC, Ray CS. Epidemiology of betel quid usage. Ann Acad Med Singapore. 2004 Jul;33(4 Suppl):31-6.
[3] Ghelardini C, Galeotti N, Lelli C, Bartolini AM1 receptor activation is a requirement for arecoline analgesia. Farmaco. 2001 May-Jul;56(5-7):383-5.
[4] Yang YR, Chang KC, Chen CL, Chiu TH. Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol. 2000 Mar 31;43(1):23-8.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Danger

Hazard Statements
H301

Precautionary Statements
P264; P270; P301+P310; P321; P330; P405; P501


Current as of May 11, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Alkaloids


PubChem
  @PubMed